Introduction
Inhaled nitric oxide (iNO) has emerged as a significant therapeutic modality in pulmonary and cardiovascular medicine. The discovery of nitric oxide as a vital biological signalling molecule has changed clinical practices, which now use it to treat pulmonary hypertension and critical care conditions. However, researchers sustain their investigations, which lead to fresh discoveries of biological pathways and new clinical uses and advanced delivery methods that may transform their therapeutic potential.
The Call for Papers Inhaled Nitric Oxide Research presents modern research breakthroughs that demonstrate nitric oxide signalling and its applications in clinical medicine and translational studies. The issue will feature state-of-the-art review articles coordinated by rising investigators and co-authored by established experts, alongside original contributions presenting novel discoveries and innovative concepts.
The research community, medical professionals, and emerging scientists are encouraged to submit their best research papers, which will enhance scientific knowledge and medical applications of Inhaled Nitric Oxide clinical research.
Scope
The special issue accepts research content that includes:
Submissions must show three essential requirements, which include methodological rigour, scientific novelty and clinical relevance. Researchers can contribute their work, which focuses on basic science and pharmacology, device engineering and clinical medicine through interdisciplinary research partnerships.
The issue particularly seeks contributions that explore emerging therapeutic indications, novel biological insights, and advancements in nitric oxide delivery systems.
Know More About This Issue
Nitric Oxide therapy new clinical indications serve as the main component that maintains blood vessel stability, controls immune functions and supports cellular communication. Research continues to explore new uses for the drug, which doctors currently use in neonatal and critical care environments to treat lung infections, heart problems and blood disorders.
This special issue presents an extensive research platform that investigates both nitric oxide’s biological functions and inhaled nitric oxide therapeutic applications. The issue will support evidence-based growth of treatment options through its combination of basic scientific study and medical research progress.
The issue aims to develop pulmonary hypertension nitric oxide research and medical usage through partnerships that connect emerging scientists with established scientific authorities.
Key Themes
The study examines how malignant wounds develop through their pathophysiological mechanisms and clinical manifestations in patients with advanced cancer.
How We Support Your Submission
The special issue manuscript requires scientists to create content that needs to be written clearly and follow journal standards. Our expert support team assists authors in developing high-quality submissions that match the Inhaled Nitric Oxide: Discoveries and Potential New Clinical Indications theme.
Our services include:
Journal Guidelines:
Important Dates
Submission Deadline: 31 December 2026
To ensure successful and timely submission to the special issue “Inhaled Nitric Oxide — Discoveries and Potential New Clinical Indications,” researchers are encouraged to leverage the expert services of the, offering comprehensive support from conceptualisation to final manuscript submission within the specified deadline.
Free Guide: How to Write the Journal Manuscript
To support researchers, the PhD Assistance Research Lab offers a free comprehensive guide on writing and preparing a high-quality journal manuscript.
Reference
Yu, B., & Safaee Fakhr, B. (2026). Inhaled nitric oxide: Discoveries and potential new clinical indications — Special issue call for papers. Elsevier. Nitric Oxide | ScienceDirect.com by Elsevier – Nitric Oxide | ScienceDirect.com by Elsevier